Clinical Trials Logo

Clinical Trial Summary

This prospective cohort study aims to determine whether maternal and neonatal outcomes are affected by GBS carrier status in women undergoing transcervical balloon catheter insertion.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03064672
Study type Interventional
Source Hadassah Medical Organization
Contact Myriam Safrai, MD
Phone 972-506998982
Email myriamsafrai@gmail.com
Status Not yet recruiting
Phase N/A
Start date December 2020
Completion date December 2021

See also
  Status Clinical Trial Phase
Withdrawn NCT04116645 - Time Frame for GBS Screening
Not yet recruiting NCT01833780 - Effectiveness of Intrapartum Group B Streptococcus (GBS) Polimerase Chain Reaction Reaction (PCR) Screening N/A
Completed NCT02497430 - Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay N/A
Completed NCT03936816 - The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis
Completed NCT03008421 - Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy N/A
Completed NCT02883270 - Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome N/A
Completed NCT04434391 - QF-PCR In GBS Diagnosis During Pregnancy
Recruiting NCT04871035 - Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)